Protocol Ledger

NCT07450547 · Phase II · RECRUITING

Phase 2 Study to Assess the Safety and Efficacy of ANG003

Interventional Phase II clinical trial protocol NCT07450547 sponsored by Anagram Therapeutics in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-04-24 Enrollment: 113 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07450547
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)113 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07450547
Protocol FieldVerified Registry Value
NCT IdentifierNCT07450547
Consolidated Lead SponsorAnagram Therapeutics
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment113 participants (ESTIMATED)
Registered Start Date2026-04-24
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI